Immature Granulocyte Absolute
IG ABS
Description
"Immature Granulocyte Absolute" test measures the number of immature granulocytes—young white blood cells—in your blood to assess bone marrow activity and immune response. Doctors often order this test when symptoms like fever, fatigue, or recurrent infections are present. Elevated levels may indicate acute infection, inflammation, or bone marrow stress. Results help clarify unexplained symptoms and guide treatment decisions. Ongoing monitoring supports early detection of hematologic changes and helps track response to infection, inflammation, or immune-related conditions.
Test Category
Blood Cells
Procedure
Invasive
Sample Type
Blood – Whole Blood
Units
Thousand Per Microliter
Procedure Category
Blood Draw
Test Group
Hematology Group, Blood Count Differentials Group
Test Group Description
Blood Count Differentials Group: This group comprises tests essential for evaluating the different types of blood cells, offering detailed insights into blood cell composition, and aiding in the diagnosis of various blood disorders. Hematology Group: Tests within this group focus on evaluating various aspects of blood health and function. These assessments provide insights into red blood cells, white blood cells, platelets, and other components of the blood.
Optimal Range
For All Individuals:
Conventional Unit: 0.00–0.03 ×10³/µL
SI Unit: 0.00–0.03 ×10³/µL
Normal Range
For All Individuals:
Conventional Unit: 0.00–0.03 ×10³/µL
SI Unit: 0.00–0.03 ×10³/µL
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Chronic myelogenous leukemia (Cancer of the blood cells)
Inflammation
Polycythemia vera (Bone marrow disorder leading to overproduction of blood cells)
Primary myelofibrosis (Bone marrow disorder causing fibrosis and impaired blood cell production)
Primary thrombocythemia (Overproduction of platelets)
- ...
Key Reasons For Testing
Infection Diagnosis: Detects bacterial infections and monitors immune response.
Sepsis Detection: Aids in identifying systemic inflammation or sepsis early.
Bone Marrow Function: Evaluates marrow response to infections or disorders.
Prognosis in Illness: Correlates levels with disease severity and outcomes.
Therapy Response: Tracks effectiveness of treatments for infections.
Leukemia Diagnosis: Helps differentiate reactive leukocytosis from myeloid neoplasms.
Stress Response: Reflects physiological responses to trauma or surgery.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Seebach JD, Morant R, Rüegg R, Seifert B, Fehr J. The diagnostic value of the leukocyte differential count in the evaluation of early infection. Am J Clin Pathol. 1997;107(5):582-591.
[2] Nigro KG, O’Riordan MA, Runge MM, Iagnemma JA. Neutrophil to lymphocyte ratio: a measure of systemic inflammation in children hospitalized with community-acquired pneumonia. J Pediatr Hematol Oncol. 2017;39(3).
[3] van der Geest PJ, Mohseni M, Brouwer R, et al. Immature granulocytes predict microbial infection and its adverse sequelae in the intensive care unit. J Crit Care. 2014;29(4):523-527.
[4] Ansari-Lari MA, Kickler TS, Borowitz MJ. Immature granulocyte measurement using the Sysmex XE-2100. Relationship to infection and sepsis. Am J Clin Pathol. 2003;120(5):795-799.
[5] Chen L, Wang W, Liang L, et al. Clinical significance of immature granulocytes in patients with sepsis. Clin Lab.2019;65(3):441-446.
[6] Gil P, Słowińska A, Rosolowski M, Zielinska-Borkowska U. Immature granulocytes as an early marker of infection in patients with systemic inflammatory response syndrome or sepsis in the emergency department. Prz Med Uniw Rzesz Inst Lek. 2015;13(1):11-15.
[7] Kruger P, Saffarzadeh M, Weber AN, et al. Neutrophils: Between host defence, immune modulation, and tissue injury. PLoS Pathog. 2015;11(3).
[8] Machin D, Cheung YB, Parmar MK. Immature granulocyte count as a prognostic marker in hospitalized patients. J Clin Pathol. 2020;73(4):222-227.
[9] Lee AJ, Kim SG, Kim J, et al. Immature granulocytes and systemic inflammation response syndrome. J Clin Lab Anal. 2016;30(5):377-381.
[10] Ecker-Eckhofen EM, Bogner-Flatz V, Hoffmann S, et al. Predictive value of immature granulocytes in patients with sepsis. Pathol Res Pract. 2018;214(11):1716-1721.
[11] Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206-217.